DANIEL MENEFEE: Open Payments
NPI 1205365913 · WORTHINGTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,648 in 71 payments from 20 companies in 2025. Trend: 2023 $782 · 2024 $1,583 · 2025 $1,648
Food & beverage: $1,648
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 11 | $339 |
| IMMUNITYBIO, INC. | 8 | $203 |
| Endo USA, Inc. | 5 | $194 |
| Sumitomo Pharma America, Inc. | 8 | $142 |
| ABBVIE INC. | 6 | $122 |
| Boston Scientific Corporation | 1 | $71 |
| Janssen Biotech, Inc. | 4 | $67 |
| PFIZER INC. | 3 | $65 |
| ACCORD HEALTHCARE, INC. | 4 | $59 |
| Verity Pharmaceuticals Inc. | 3 | $57 |
Products named: PROVENGE, ANKTIVA, BOTOX, ORGOVYX, XIAFLEX, AVEED, XTANDI, General - Kidney Stone Disease.
Industry payments across OH — which companies pay providers there.
